Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle Zuniga

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Progress in Neurobiology|July 16, 2023
Selective neuronal vulnerability to deficits in RNA processingGabrielle Zuniga, Bess Frost
BMC Genomics|October 14, 2025
Long-read sequencing-based analyses of the adult Drosophila brain transcriptome in physiological and pathological settingsPaulino Ramirez, Gabrielle Zuniga, Elizabeth Ochoa, et al.
Cell Reports Methods|September 26, 2022
Tau<sup>LUM</sup>, an <i>in vivo Drosophila</i> sensor of tau multimerization, identifies neuroprotective interventions in tauopathySimon A Levy, Gabrielle Zuniga, Elias M Gonzalez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 13, 2022
Tau-induced deficits in nonsense-mediated mRNA decay contribute to neurodegenerationGabrielle Zuniga, Simon Levy, Paulino Ramirez, et al.
Aging Cell|June 27, 2024
Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of diseaseGabrielle Zuniga, Sakie Katsumura, Jasmine De Mange, et al.
Cell Reports|July 16, 2020
Pathogenic Tau Causes a Toxic Depletion of Nuclear CalciumRebekah Mahoney, Elizabeth Ochoa Thomas, Paulino Ramirez, et al.
Progress in Neurobiology|October 20, 2021
Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous systemPaulino Ramirez, Gabrielle Zuniga, Wenyan Sun, et al.
NPJ Dementia|March 19, 2025
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer's disease (ART-AD)A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentA Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Progress in Neurobiology|July 16, 2023
Selective neuronal vulnerability to deficits in RNA processingGabrielle Zuniga, Bess Frost
BMC Genomics|October 14, 2025
Long-read sequencing-based analyses of the adult Drosophila brain transcriptome in physiological and pathological settingsPaulino Ramirez, Gabrielle Zuniga, Elizabeth Ochoa, et al.
Cell Reports Methods|September 26, 2022
Tau<sup>LUM</sup>, an <i>in vivo Drosophila</i> sensor of tau multimerization, identifies neuroprotective interventions in tauopathySimon A Levy, Gabrielle Zuniga, Elias M Gonzalez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 13, 2022
Tau-induced deficits in nonsense-mediated mRNA decay contribute to neurodegenerationGabrielle Zuniga, Simon Levy, Paulino Ramirez, et al.
Aging Cell|June 27, 2024
Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of diseaseGabrielle Zuniga, Sakie Katsumura, Jasmine De Mange, et al.
Cell Reports|July 16, 2020
Pathogenic Tau Causes a Toxic Depletion of Nuclear CalciumRebekah Mahoney, Elizabeth Ochoa Thomas, Paulino Ramirez, et al.
Progress in Neurobiology|October 20, 2021
Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous systemPaulino Ramirez, Gabrielle Zuniga, Wenyan Sun, et al.
NPJ Dementia|March 19, 2025
A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD)A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer's disease (ART-AD)A Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentA Campbell Sullivan, Gabrielle Zuniga, Paulino Ramirez, et al.
Pageof 1